Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies - Summary - MDSpire

Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies

  • By

  • Jaime Francisco Larre-Guerra

  • Álvaro Castrillo-Capilla

  • Macarena Garbayo-Bugeda

  • Andrea Kallmeyer

  • Ester Cánovas

  • María Nieves Tarín

  • Carmen Cristóbal

  • Ana Huelmos

  • Carlos Gutiérrez-Landaluce

  • José Antonio Esteban Chapel

  • Junior Senra

  • María Luisa González Casaus

  • Joaquín Alonso

  • Lorenzo López-Bescós

  • Ignacio Mahíllo

  • Óscar Lorenzo

  • José Manuel Rubio-Campal

  • José Tuñón

  • April 20, 2026

  • 0 min

Share

Objective:

To analyze the predictive ability of FGF23 and related mineral metabolism components for the development of atrial fibrillation (AF) after acute coronary syndrome (ACS), emphasizing its clinical significance.

Key Findings:
  • FGF23 levels were identified as a potential predictor of AF following ACS, with age stratification revealing differing predictive factors for AF development, indicating the need for tailored approaches in risk assessment.
  • Mineral metabolism components showed significant associations with AF risk.
Interpretation:

The findings suggest that FGF23 and other mineral metabolism markers may be useful in predicting AF after ACS, highlighting the need for further research to explore their role in clinical practice.

Limitations:
  • The study was limited to a specific population in Madrid, which may affect generalizability.
  • Exclusion criteria may have led to selection bias.
  • The follow-up duration may not have been sufficient to capture all AF events.
Conclusion:

FGF23 and related biomarkers could serve as important predictors for AF following ACS, warranting further investigation to enhance prevention strategies.

Original Source(s)

Forecasting Atrial Fibrillation Following Acute Coronary Syndrome: Findings from the BACS and BAMI Studies

  • by Jaime Francisco Larre-Guerra, Álvaro Castrillo-Capilla, Macarena Garbayo-Bugeda, Andrea Kallmeyer, Ester Cánovas, María Nieves Tarín, Carmen Cristóbal, Ana Huelmos, Carlos Gutiérrez-Landaluce, José Antonio Esteban Chapel, Junior Senra, María Luisa González Casaus, Joaquín Alonso, Lorenzo López-Bescós, Ignacio Mahíllo, Óscar Lorenzo, José Manuel Rubio-Campal, José Tuñón

  • April 20, 2026

Related Content

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.

Low Follow-Up After Behavioral ED Care

Follow-up occurred after fewer than 15% of mental health ED visits and about 11% of substance use–related visits in Washington Medicaid claims.

Low admission pulse pressure and increased in-hospital mortality in patients with heart failure